Combination Therapy for Alzheimerʼs Disease

Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice

(2009) Hilda Martinez-Coria et al.   AMERICAN JOURNAL OF PATHOLOGY

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

(2009) Martin R. Farlow et al.   CURRENT MEDICAL RESEARCH AND OPINION

Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease

(2009) James Folwell et al.   EXPERIMENTAL NEUROLOGY

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

(2009) Jason T. Olin et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

(2009) O L Lopez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

(2009) Susan D Rountree et al.   Alzheimers Research & Therapy

Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease

(2008) Alireza Atri et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research